Loading…
Loading…
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for SCD and 80,000+ other tickers.
See exactly how SCD's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SCD and 80,000+ other tickers.
The LMP Capital and Income Fund Inc. operates as a closed-end balanced mutual fund, primarily overseen by Legg Mason Partners Fund Advisor, LLC. Additional management responsibilities are shared with Clearbridge Investments, LLC, Western Asset Management Company Limited, and Western Asset Management Company. Its investment mandate extends globally, encompassing both public equity and fixed-income securities from businesses spanning various sectors. Key holdings include shares of large-capitalization firms, corporate bonds and notes of intermediate maturity with a minimum A- rating, both…
LMP Capital and Income Fund Inc. (NYSE: SCD - Get Free Report) shares crossed below its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $15.40 and traded as low as $15.35. LMP Capital and Income Fund shares last traded at $15.46, with a volume
Galmed has developed, in collaboration with Barcode Nanotech, a unique proprietary lipid nanoparticles (LPNs) novel formulation of Aramchol that penetrates the heart tissue and redirects Aramchol's biodistribution away from liver-hepatocytes to the heart's muscle. Cardiac fibrosis is a major driver of chronic heart failure, the leading cause of death globally, responsible for an estimated 20.5 million deaths in 2025.
The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 9.8% plus yield and nearly 7.5% NAV discount. Selections emphasize sector diversification, long-term outperformance, sustainable distributions, and attractive valuations, with a focus on both equity and credit-oriented CEFs. CEFs are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone.
LMP Capital and Income Fund maintains a 9.2% yield, with management expressing confidence in sustaining current distributions through August. Recent performance and distribution consistency have been concerns, leading to a hold rating on SCD. Franklin Templeton's management strategy and risk profile are key considerations for SCD's forward outlook.
[url="]Vertex Pharmaceuticals Incorporated[/url] (Nasdaq: VRTX) today announced data demonstrating the clinical benefits of CASGEVYÂ (exagamglogene autotemcel